Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07529808) titled 'Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma' on April 1.
Study Type: Interventional
Study Design:
Allocation: Non-Randomized. Intervention model: Sequential Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: BigHat Biosciences, Inc.
Condition:
Gastric Cancer
Gastric Adenocarcinoma
Gastric (Stomach) Cancer
Gastroesophageal Adenocarcinoma
Gastroesophageal Cancer (GC)
Gastroesophageal Junction (GEJ) Adenocarcinoma
Gastroesophageal Junction (GEJ) Cancer
Gastrointestinal Cancer Metastatic
Gastrointestinal Adenocarcinoma
Gastrointestinal Cancers
Colorectal (Co...